Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Classificação em ações #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Preço da ação
$481.73
Valor de mercado
$377.65B
Variação (1 dia)
-0.96%
Variação (1 ano)
50.07%
País
CH
Negociar Roche Holding AG (RO)

Categoria

Receita da Roche Holding AG (RO)
Receita em Dec 2025 TTM: $77.52B
De acordo com os últimos relatórios financeiros da Roche Holding AG, a receita atual da empresa (TTM) é $77.52B. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Roche Holding AG de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
$79.67B 2.77%
US
$97.93B 26.33%
US
$64.39B -16.94%
US
$66.40B -14.34%
US
$56.26B -27.43%
CH